Data / Form D filings / Aveta Biomics, Inc.
Aveta Biomics, Inc.: Form D filings
Aveta Biomics, Inc., a pharmaceuticals company in Bedford, MA, filed 3 Form D notices with the SEC between 2018 and 2025. The latest, on March 19, 2025, reports $4.5 million sold of a $8 million offering to 36 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 110 GREAT ROAD, SUITE 302, Bedford, MA, 01730
- Phone
- (339) 927-5994
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1734691
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 19, 2025 | New notice | $8,000,000 | $4,455,040 | $3,544,960 | 36 | May 30, 2024 | sec.gov |
| Feb 23, 2022 | New notice | $5,000,002 | $600,019 | $4,399,983 | 13 | Feb 8, 2022 | sec.gov |
| Mar 19, 2018 | New notice | $2,500,000 | $1,100,000 | $1,400,000 | 4 | Mar 2, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| S. P. Kothari | Director | |
| Parag Mehta | Executive Officer, Director | |
| Bharat Tewarie | Director | |
| Peter Dolan | Director | |
| David Page | Director |
Other pharmaceuticals companies in Massachusetts that filed recently
- Land Therapeutics Inc. $17.5 million · Oct 21, 2026
- Crosslink Therapeutics Inc. $5.5 million · Oct 20, 2026
- Sentonix, Inc. $12.7 million · Aug 20, 2026
Every Form D from the week of Mar 17, 2025 · All recent filings in Massachusetts · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Aveta Biomics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.